Skip to content

Clinical trials

Phase 2 Scleroderma, Systemic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20082
20101
20111
20121
20142
20151
20161
20191
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany2
Heidelberg University2
ISDIN2
Actelion1
Active Biotech AB1
Artiva Biotherapeutics, Inc.1
Bayer1
Boehringer Ingelheim1
Celgene1
Heinrich-Heine University, Duesseldorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic18
Scleroderma, Diffuse3
Hypertension, Pulmonary2
Raynaud Disease2
Arthritis, Rheumatoid1
Familial Primary Pulmonary Hypertension1
Fibrosis1
Lung Diseases, Interstitial1
Myositis1
Peripheral Vascular Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.